We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Inappropriate Laboratory Testing Found Throughout Medicine

By LabMedica International staff writers
Posted on 02 Dec 2013
Laboratory testing is the single highest-volume medical activity and drives clinical decision-making across medicine with over five billion tests performed each year in the USA.

The overall landscape of inappropriate testing, which is thought to be dominated by repeat testing, is unclear. More...
Systematic differences in initial versus repeat testing, measurement criteria, and other factors would suggest new priorities for improving laboratory testing.

Scientists at the Harvard Medical School (Boston, MA, USA) and colleagues from Beth Israel Deaconess Medical Center (BIDMC; Boston MA, USA) performed a multi-database systematic review on published studies from 1997–2012. For measures of overutilization, they determined whether the inappropriateness criteria were objective or subjective; restrictive, permissive, or both; and whether they involved initial testing, repeat testing, or both. Test volume, low, medium, or high was also determined.

From these measurements, they set about estimating the overall prevalence of inappropriate testing, including overuse, tests that are ordered but not indicated, and underuse tests that are indicated but not ordered. They also distinguished between inappropriate initial testing, during a clinician's first evaluation of a patient or in response to new signs or symptoms, and inappropriate repeat testing, which occurs when the same tests are repeated, often multiple times, during a patient's hospitalization.

The authors found that not only was there a 30% overall rate of test overuse, there was a similar rate of underuse. On average, the available evidence suggests that underutilization is more prevalent than overutilization, 44.8% versus 20.6%. Ramy Arnaout, MD, DPhil, the senior author, said, “It's not ordering more tests or fewer tests that we should be aiming for, it's ordering the right tests, however few or many that is. Remember, laboratory tests are inexpensive. Ordering one more test or one less test isn't going to ‘bend the curve,’ even if we do it across the board. It's everything that happens next: the downstream visits, the surgeries, the hospital stays that matters to patients and to the economy and should matter to us.”

William Taylor, MD, a clinician in BIDMC's Division of General Medicine and Primary Care, said, “Because laboratory tests play such a crucial and ubiquitous role in medicine, efforts to identify opportunities for improvement in the selection of tests have the potential to contribute greatly to the care patients receive. By drawing attention to this important topic, the authors are setting the stage for further work to help more patients benefit from proper test selection, while protecting patients from the potential harm and wasted resources induced by unnecessary tests.” The study was published on November 15, 2013, in the journal Public Library of Science ONE.

Related Links:

Harvard Medical School
Beth Israel Deaconess Medical Center 



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new RABTA sets a high standard in laboratory diagnostics (Photo courtesy of Randox)

Pioneering Analyzer with Advanced Biochip Technology Sets New Standard in Lab Diagnostics

A state-of-the-art analyzer combines advanced technology with exceptional efficiency to meet the demanding needs of modern laboratories. Randox Toxicology (Antrim, Ireland) has launched its pioneering... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.